Myriad Genetics will present new data on its Precise MRD test for renal cell carcinoma at the AACR Annual Meeting. Myriad Genetics, Inc. announced that it will present new clinical data on its Precise ...
Founded in 2015, Tempus built a platform designed to turn real-world clinical information into structured, centralised, and ...
SALT LAKE CITY, June 02, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (MYGN), (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced new molecular residual ...
Optimize test efficiency for 1.6T optical transceiver testing for R&D and manufacturing of next-generation optical interconnects for data centers AI clusters Maximize data center AI network ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc (VCYT). (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new data showing that its whole-genome sequencing (WGS)-based ...
In the world of textiles, nonwovens, and technical fabrics, performance is often measured by the unseen. How does a fabric ...
If there’s one thing I’ve learned after nearly two decades working with wellness brands, it’s that longevity is a mindset.
Meta-analysis of diagnostic test accuracy studies is an increasingly pivotal approach in evidence-based medicine, enabling the synthesis of data from multiple investigations to assess the performance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback